Dr. Gilda B. Digman, MD

Dr. Digman practices at Baptist Hospital - Urgent Care in Pensacola, Florida.

Dr. Digman's NPI, 1457849978, was assigned on April 30, 2018. Dr. Digman graduated from Joe R. & Teresa Lozano Long School of Medicine in 2018. Dr. Digman holds Florida license ME159155.

Dr. Digman's primary practice is Baptist Hospital - Urgent Care, at 1000 W Moreno St, Pensacola, FL 32501. The practice phone is (850) 908-8888.

Dr. Digman's primary practice is Baptist Hospital - Urgent Care in Pensacola, Florida. Dr. Digman is also affiliated with Baptist Hospital. The medical group on file is Baptist Medical Group Ladies First OB/GYN. Dmand AI also links Dr. Digman to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Digman practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Digman's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Digman is board certified in urology by the American Board of Urology. Dr. Digman is licensed in Florida.

Dmand AI lists enlarged prostate and urinary endoscopy among the conditions Dr. Digman treats.

CMS data shows 591 Medicare services from Dr. Digman across 8 procedure codes in 2024, for 305 Medicare patients. Medicare paid $50,572 for them.

CMS counts 305 Medicare patients who saw Dr. Digman in 2024. The largest group is 65 to 74, with 135 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Digman's median patient age at 71, with 35% women.

In 2024, Dr. Digman wrote 632 Medicare Part D claims for 187 patients. 91% of them were for generic drugs. CMS names the drug for 556 of them, across 14 drugs with 11 or more claims each, at $47,415 in total drug cost. In 2021, CMS named 47 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Digman for performance year 2024, reported as part of a group. Dr. Digman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 24 procedures of prostate resection by Dr. Digman, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Digman in 2018. 2018 was the busiest year, with 3. The most frequent topics are Image-Guided Biopsy. Dr. Digman has published most often in BMJ Case Rep. Dr. Digman's most frequent co-authors are Dharam Kaushik, MD and Marlo Magsanoc Nicolas, MD.

CMS Open Payments shows 68 general payments to Dr. Digman from 18 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 59% of the total. Boston Scientific Corporation paid the most, $3,450.

Dr. Digman graduated from Joe R. & Teresa Lozano Long School of Medicine in 2018.

Dr. Digman is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.